SPRO
Spero Therapeutics, Inc. · Healthcare
CEO and President Ankit Mahadevia sold $117K of Spero Therapeutics, Inc.
Sold$116,666
$14.58Price
8,000Shares
−5%Stake
What SPRO did after the filing
- The stock from Wed, Dec 29 close, $15.25
- −34.0%
- S&P 500, same days
- −5.9%
Measured over 30 trading days, to the Feb 10 close.
Traded Mon, Dec 27. Filed Wed, Dec 29, 1:26 PM ET, during the session. Returns use the Dec 29 close and the Feb 10 close. Not investment advice.